Latest Biotech News

Biotech-focused exchange-traded funds have posted double-digit gains over the past six months, with XBI up roughly 34%, IBB up ~25% and ARKG surging about 42% in the recent stretch. Analysts...

Walgreens and other community pharmacies are positioning themselves as strategic partners for biopharma to improve specialty medication adherence and patient support, driven by rising advanced...

Researchers compared four exome capture platforms using the DNBSEQ high-throughput sequencer to benchmark coverage, on-target rates and variant-calling performance. The study provides sequencing...

Industry reports promoted agile clinical site networks as a way to accelerate oncology trials by aligning sponsors, trial sites and investigators on common operational goals. The piece advised...

Researchers developed 3D-printed scaffold models to improve glioblastoma drug screening, enabling more physiologically relevant tumor architectures than traditional 2D cultures. The platform,...

Novartis announced its agreement to acquire Avidity Biosciences for roughly $12 billion in cash, a deal that hands Novartis a portfolio of RNA-based candidates targeting neuromuscular diseases....

Flagship Pioneering launched Expedition Medicines, a startup using artificial intelligence to map the chemistry of small‑molecule binding against proteins historically deemed undruggable....

Town Hall Ventures closed a $440 million fund to back startups applying artificial intelligence to expand healthcare access and outcomes for underserved populations. The firm positioned the fourth...

A recent study found that long‑acting injectable formulations of buprenorphine reduce the need for inpatient services among patients with opioid use disorder, shifting care from hospitals to...

Researchers demonstrated that rotavirus RNA levels detected in wastewater correlate with population‑level infection rates and vaccination coverage across the United States. The study used...

A team led by Zhou et al. used metagenomic sequencing to identify strain‑level diversity among bacterial pathogens causing pneumonia, improving resolution beyond species identification. The study...

A multicenter consortium validated artificial‑intelligence models for classifying urothelial neoplasms on digital pathology slides, reporting robust performance across institutions. The research...

Recent reviews and studies synthesize advances in CAR‑T and CAR‑NK cell therapies for acute myeloid leukemia (AML), outlining engineered strategies to overcome antigen heterogeneity and myeloid...

Researchers developed 3D‑printed scaffold models to better mimic glioblastoma microenvironments and improve preclinical drug screening fidelity. The scaffolds preserved tumor heterogeneity and...

A study by Wang et al. identified FBXL5 as a molecular driver of oxaliplatin resistance in iron‑rich colorectal cancers and showed that targeting FBXL5 sensitizes tumors to chemotherapy by...

Novartis agreed to acquire Avidity Biosciences in a cash transaction that values the RNA-focused developer at about $12 billion. The deal, announced Sunday, buys Novartis three late-stage programs...

Researchers unveiled a nanopore sequencing workflow that analyzes plasma cell‑free DNA to report both tissue‑of‑origin signals and pathogen presence from a single blood draw. The approach was...

A team led by Zhou et al. published a strain‑level metagenomic sequencing study of pneumonia pathogens, demonstrating the ability to resolve intra‑species variation directly from clinical samples....

Researchers reviewed recent preclinical and early clinical work advancing CAR‑T and CAR‑NK approaches against acute myeloid leukemia (AML). The report synthesizes new antigen targets, engineering...

A preclinical study from Xu, Zhang and Yu outlines nanoparticle strategies designed to modulate macrophage behavior in atherosclerotic plaques. Investigators report targeted delivery systems that...